Andoni, Tala
Wiggins, Jennifer
Robinson, Rachel
Charlton, Ruth
Sandberg, Michael
Eeles, Rosalind
Funding for this research was provided by:
NIHR
Article History
Received: 21 August 2021
Accepted: 20 January 2022
First Online: 21 February 2022
Competing interests
: Professor Rosalind Eeles: 1. GU-ASCO meeting in San Francisco - Jan 2016 – Honorarium as speaker $500 2. RMH FR meeting – Nov 2017 – support from Janssen, honorarium as speaker £1100 (Title: Genetics and Prostate Cancer) 3. University of Chicago invited talk May 2018 – Honorarium as speaker $1000 4. EUR 200 educational honorarium paid by Bayer & Ipsen to attend GU Connect “Treatment sequencing for mCRPC patients within the changing landscape of mHSPC” at a venue at ESMO, Barcelona, 28 September 2019 5. Prostate Dx Advisory Panel – Member of external Expert Committee. 30th June 2002/3 hours/ £900. The remaining authors have no conflicts of interest to declare.